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Summary
Glycosyltransferases (GTs) catalyze the synthesis of
the myriad glycoconjugates that are central to life.
One of the largest families is GT4, which contains sev-
eral enzymes of therapeutic significance, exemplified
by WaaG and AviGT4. WaaG catalyses a key step in li-
popolysaccharide synthesis, while AviGT4, produced
by Streptomyces viridochromogenes, contributes to
the synthesis of the antibiotic avilamycin A. Here we
present thecrystal structureofbothWaaGandAviGT4.
The two enzymes contain two ‘‘Rossmann-like’’ (b/a/b)
domains characteristic of the GT-B fold. Both recogni-
tion of the donor substrate and the catalyticmachinery
is similar to other retaining GTs that display the GT-B
fold. Structural information is discussed with respect
to the evolution of GTs and the therapeutic signifi-
cance of the two enzymes.
Introduction
Glycosyltransferases (GTs) are central to life. The syn-
thesis of the glycosidic bond impacts not only on the
formation of structural and food storage polysaccha-
rides, but also on the metabolic orchestration of small
molecules and the formation of numerous glycolipids,
glycopeptides, and lipopolysaccharides (LPSs). GTs
harness activated sugar donors, typically nucleotide
or lipid-phospho sugars, to drive glycosyl transfer to
the appropriate acceptor. GT genes represent approxi-
mately 1%–2% of all coding regions of genomes, and
there are around 20,000 open-reading frames predicted
as GTs (by virtue of similarity to characterized enzymes)
known to date [1, 2]. These sequences are currently
classified into 87 distinct sequence families (CAZy; car-
bohydrate-active enzymes database at http://www.
cazy.org/). Of these families, just 21 (GT1, 2, 5–9, 13,
15, 20, 27, 28, 35, 42–44, 63, 64, 72, 78, and 80) currently
have a known three-dimensional structure. In contrast to
glycoside hydrolases, which display a myriad of topolo-
gies, GT structures have, thus far, revealed just two folds
(and variants thereof), termed GT-A and GT-B [2–4].
*Correspondence: davies@ysbl.york.ac.ukGTs specifically catalyze a reaction of defined stereo-
chemistry; in other words, the configuration of the acti-
vated donor may be inverted or retained, leading to the
terms ‘‘inverting’’ and ‘‘retaining’’ enzymes. Currently,
there is no correlation between the overall fold of the
GT and its mechanism of action: both inverting and
retaining enzymes of both fold types are known. Further-
more, most eukaryotic and bacterial genomes display
a wide diversity of GTs from many of the sequence-
derived families. Homo sapiens, for example, have en-
zymes that sparsely populate 42 of these families.
Whereas most organisms marshal a similarly diverse ar-
ray of GTs, the sequences of Archael genomes, over 20
of which are now known, reveal a different picture. Prim-
itive Archae often display GTs from just two sequence-
based families: GT2 and GT4. GT2 enzymes form a family
of inverting enzymes, while all (currently characterized)
GT4 enzymes are retaining. Thus, it seems likely that
GT2 and GT4 are the ancestral inverting and retaining
families from which enzymes of both stereochemistries
have evolved. While GT2 enzymes display the GT-A
fold [5], it was unconfirmed whether GT4 GTs adopt the
GT-B fold.
GT4 is one of the largest of all the GT families, with over
3700 members. This family contains examples of en-
zymes that not only utilize nucleotide-sugar donors,
but also simple phospho-sugars and lipid-phospho
sugar donors, perhaps hinting at the ancient origin of
the family. Family GT-4 functions appear as diverse as
their sequences, reflecting differences in both donor
and acceptor specificity. Several enzymes in this family
are of potential therapeutic significance, exemplified
here by WaaG and AviGT4. WaaG is an a-1,3 glucosyl-
transferase, which transfers a glucose from UDP-Glc
onto L-glycero-D-manno-heptose II, contributing to the
core structure of LPSs [6, 7], while Bechtold’s outstand-
ing work has shown that AviGT4 catalyses the attach-
ment of an as-yet undefined precursor of the eurekanate
sugar moiety to L-lyxose [8] during the synthesis of the
orthosomycin antibiotic avilamycin A [9], respectively
(Figure 1). Although both located in family GT4, WaaG
and AviGT4 display just 16% sequence identity.
Here, we present the 3D structures, determined by
X-ray crystallography, of the first two family GT4 mem-
bers, WaaG and AviGT4. Structural approaches provide
insight into these two systems, where lack of substrate
availability, or even identification, precludes kinetic ap-
proaches. We show that both enzymes exhibit a GT-B
fold, consistent with the hypothesis that GT2 and GT4
are progenitors of the numerous GT families, while struc-
ture-based sequence alignments of the C-terminal
domains of diverse GT-B enzymes suggest a structural
basis for the evolution of enzyme mechanism.
Results and Discussion
Initial attempts to produce AviGT4 and WaaG generated
insoluble recombinant protein. The inclusion of Triton
X-100 in the cell lysis buffer yielded soluble forms of
both GTs, and the proteins remained soluble despite
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(A) Schematic diagram of E. coli LPS. GlcN, D-glucosamine; Hep, L-glycero-D-manno-heptose; P, phosphate; EtNP, 2-aminoethyl phosphate;
Glc, D-glucose; Gal, D-galactose. WaaG is responsible for the addition of the first glucose moiety via an a-1,3 glycosidic linkage to Hep II.
(B) Structure of the antibiotic avilamycin A. Disruption of the avigt4 gene results in a product lacking the eurekanate moiety (boxed) normally
bonded to the L-lyxose residue [8].the exclusion of the detergent from the subsequent
buffers used in the purification schemes. Thus, in the
absence of detergent, the two GTs appear to bind to
hydrophobic particulate matter present in Escherichia
coli cells; however, once this material had been removed
when the recombinant enzymes were bound to the col-
umn matrix, the inclusion of Triton X-100 was no longer
required to maintain the two proteins in soluble form. It is
generally recognized that the production of soluble re-
combinant GTs is problematic, and the capacity of these
proteins to bind to hydrophobic structures in E. coli may
contribute to the general insolubility of recombinant GTs
expressed in E. coli.
GT4 Glycosytransferases Display the GT-B Fold
The structure of WaaG was solved by single-wavelength
anomalous dispersion (SAD) with a selenomethionine
(SeMet) version of the protein, at a resolution of 1.6 A˚
(Table 1), in the presence of UDP, while the crystal struc-
ture of AviGT4 was determined by multiple-wavelength
anomalous dispersion (MAD) methods, also employing
SeMet protein to a resolution of 2.1 A˚ (Table 1). The
electron density allows for the modeling of the WaaG
sequence as a continuous chain from residue Ile2 to
Gly371 (Figure 2). The WaaG sequence folds into two
‘‘Rossmann-like’’ (b/a/b) domains, with a similar topol-
ogy of other previously described GTs displaying the
GT-B fold. The N-terminal domain comprises residues
Ile2–Gly168 and displays seven parallel b strands
flanked by five a helices on both sides of a characteristi-
cally twisted b sheet. The C-terminal domain (residues
Ile169–Gly371) displays six parallel b strands flanked
by six a helices, and terminates with the recurrent
pattern of a kinked a helix (Ser338–Gly371) that crosses
over to the N-terminal domain (residues Ser359–Gly371), adding an extra a helix to the N-terminal Ross-
mann-like fold.
Crystals of AviGT4 contain two copies of the protein in
the asymmetric unit, interacting over an area of 3750 A˚2
per chain, which have both been modeled from residues
Pro13–Lys352. AviGT4 also displays two Rossmann-like
(b/a/b) domains, and thus also adopts the GT-B fold. The
N-terminal domain comprises residues Pro13–Pro156,
and its core is composed of six parallel b strands alter-
nating with three connecting a helices (Figure 2B). The
C-terminal domain (Val157–Lys352) is composed of a
central parallel b sheet of six strands flanked by seven
a helices. As with WaaG and all known GT-B enzymes
(reviewed in [10]), the last C-terminal helix is kinked at
residue Trp329, located in the interface between the
two domains, and the rest of the helix crosses to the
N-terminal domain (residues His331–Lys352).
Structural homology searches (DALI [11]) reveal that
the closest, currently deposited, structural neighbor to
WaaG structure is the retaining GT-20, OtsA (the treha-
lose-6-phosphate synthase whose E. coli-derived struc-
ture is known; DALI Z-score, 25.6), with an rmsd of 3.4 A˚
and with which WaaG shares 12% sequence identity.
The Agrobacterium tumefaciens glycogen synthase,
GagA, also retaining, from family GT5 appears second
(DALI Z-score, 21.4; 13% sequence identity). Interest-
ingly, the next closest structural match is not with a GT
but with a UDP-sugar epimerase (E. coli UDP-N-acetyl-
glucosamine 2-epimerase), with a DALI Z-score of 20.4
and 12% sequence identity. Homology searches for
AviGT4 reveal similar results; the closest structural
homologs represented by the A. tumefaciens glycogen
synthase (DALI Z-score, 22.5) and GT20 OtsA (DALI Z-
score, 22.4). A family GT-35 retaining glycogen phos-
phorylase from Oryctolagus cuniculus (rabbit) appeared
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1145Table 1. Data Collection and Refinement Statistics for AviGT4 and the GT4 Enzyme WaaG
AviGT4 (SeMet) AviGT4 + UDP-Glc WaaG (SeMet) + UDP WaaG + UDP-2F-Glc
Data Collection
Space group P21 P1 P212121 P212121
Cell dimensions
a, b, c (A˚) 47.5, 73.8, 92.1 51.5, 74.4, 90.6 50.7, 88.7, 89.6 50.7, 88.3, 89.3
a, b, g () 90.0, 90.6, 90.0 89.9, 92.7,100.7 90.0, 90.0, 90.0 90, 90, 90
Peaka Peak
Wavelength (A˚) 0.97770 0.98000 0.97950 0.93300
Resolution (A˚) 40.00–2.10 90.53–2.30 33.6–1.60 40.67–1.50
Rmerge 0.064 (0.183) 0.089 (0.324) 0.058 (0.196) 0.126 (0.283)
I/sI 24.7 (8.1) 9.8 (2.6) 22.1 (8.6) 13.0 (2.2)
Completeness (%) 99.7 (98.1) 96.9 (92.3) 100 (100) 99.0 (93.6)
Redundancy 7.2 (6.4) 2.5 (2.4) 7.2 (7.3) 4.3 (2.6)
Refinement
Resolution (A˚) 20.00–2.10 20.00–2.30 20.00–1.60 20.00–1.50
No. reflections 35,293 53,958 51,242 61,003
Rwork/Rfree 0.17/0.23 0.20/0.26 0.17/0.20 0.18/0.22
B factors
Protein 17 35 12 10
/UDP/UDP-2FGlc No ligand 44 7 7
Water 23 36 29 24
Rms deviations
Bond lengths (A˚) 0.017 0.019 0.009 0.011
Bond angles () 1.597 1.863 1.192 1.945
a Although the structure was solved by MAD, only the peak data statistics used for refinement are given.immediately below, with a DALI Z-score of 15, and, more
distantly, GtfB, an antibiotic modifying, but inverting, GT
from family GT1 (DALI Z-score, 12.8).Donor Substrate Recognition by AviGT4 and WaaG
The structure of AviGT4 was solved in complex with
UDP-Glc at a resolution of 2.3 A˚, and that of WaaG solvedFigure 2. Three-Dimensional Structures of Two Family GT4 GTs
(A) Divergent (wall-eyed) stereo cartoon of the UDP-2FGlc complex of the GT4 enzyme WaaG from E. coli. The structure is ‘‘color-ramped’’
from N terminus (blue) to C terminus (red).
(B) Divergent (wall-eyed) stereo cartoon of the UDP complex of the GT4 enzyme AviGT4 from Streptomyces viridochromogenes Tu¨57.
This figure was drawn with MOLSCRIPT [42].
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GT4 WaaG
(A) Observed electron density (calculated
with the coefficients 2Fobs 2 Fcalc and acalc)
for the UDP-2F-glucose complex of E. coli
WaaG (drawn with BOBSCRIPT [43]).
(B) Schematic diagram of the interactions of
WaaG with UDP-2F-glucose.in complex with UDP-2-deoxy-2-fluoro glucose (UDP-
2FGlc; synthesis described in [12]) at a resolution of
1.5 A˚, providing insight into nucleotide-sugar donor
binding (Figures 3 and 4). The interactions of the uracil
and ribose moieties were as observed previously for
GT-B clan retaining GTs, exemplified by GT20 treha-
lose-6-phosphate synthase OtsA [12, 13]. Uracil recogni-
tion is conferred by hydrogen bonds to the main chain
carbonyl and amide of Arg261, by O7 and N3, respec-
tively. Ribose binding is conferred by Glu289, which is
a signature of the GT-B fold UDP-dependent enzymes
(e.g., [10, 13–18]).
In the donor sugar site itself, while there are many sim-
ilarities with the recognition of glucose in diverse GT-B
enzymes, such as glycogen and maltodextrin phosphor-
ylases [19, 20], OtsA [12, 13], and glycogen synthase
[21], there are also significant differences that had notpreviously been predicted. Recognition of Glc O3 and
O4 by two main-chain amide hydrogens and a carboxyl-
ate is again seen with WaaG; but here the carboxylate
moiety is donated by a glutamate (Glu281) in place of
the aspartate observed in OtsA. In 2001, Wrabl and Gri-
sin proposed a sequence-derived superfamily of GT-B
fold GTs, which they termed the ‘‘glycogen phosphory-
lase GT’’ (GPGTF) superfamily [18]. In the GPGTF super-
family, a carboxylate at this position, described above,
is indeed considered the second signature motif of the
superfamily. Most intriguingly, the 3D structure reveals
that WaaG provides a different environment around O6
to all enzymes described previously. In glycogen and
maltodextrin phosphorylases (enzymes that are mecha-
nistically and structurally related to GT-B fold GTs), OtsA
and glycogen synthase O6 interacts with a conserved
histidine side chain, the main-chain carbonyl of whichFigure 4. Overlay of the Active Centers of GT4 Enzymes AviGT4 and WaaG
The UDP-2FGlc complex of WaaG is shown in cyan with AviGT4 in yellow. Electron density for the ordered UDP portion of the UDP-Glc in
complex with AviGT4 is shown in red and is an electron density map calculated with the coefficients 2Fobs 2 Fcalc and acalc and contoured
at 1.2s. AviGT4 residues discussed in the text are shown labeled. This figure was drawn with BOBSCRIPT [43].
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stabilizing the incipient oxocarbenium-ion-like transition
state [22] (and for review, see [23]). In WaaG, an alanine is
present in this position and, while its main-chain car-
bonyl is again poised above C1, the absence of the
side-chain imidazole allows Asp19 to bind O6 in its place.
WaaG also provides a different environment around O2
(here present as a fluorine substituent of the 2-deoxy-
2-fluoro sugar) and around the b-phosphate of UDP.
Unique to WaaG is an arginine residue, Arg208, which in-
teracts with the superfamily invariant carboxylate of
Glu281 and with both F2 and O2 of the b-phosphate.
The orthosomycin class of antibiotics, which are effec-
tive against many gram-positive bacteria, including
emerging pathogens such as glycopeptide-resistant en-
terococci, methicillin-resistant staphylococci, and peni-
cillin-resistant pneumococci [24], consist of a dichloro-
isoeverninic acid moiety and a heptasaccharide side
chain (Figure 1) [25]. AviGT4 catalyzes the attachment
of an as-yet undefined (both in terms of nucleotide
and sugar) precursor of the eurekanate sugar moiety to
L-lyxose (Figure 1B) [8]. Furthermore, as the eurekanate
moiety displays a double glycosidic linkage to the
lyxose, there also must be chemical events subsequent
to glycosyl transfer; indeed in the absence of structural
information, it is unclear as to which bond is formed by
the AviGT4 catalyzed step. The crystal structure of the
enzyme implicates UDP as a potential dinucleotide com-
ponent of the donor substrate. Indeed, the interactions
between AviGT4 and the uracil base and ribose sugar
of the dinucleotide are conserved in retaining GTs that
display the GT-B fold (Figure 4). Thus, uracil recognition
is primarily conferred by hydrogen bonds between O7
and N3, respectively, and the main-chain carbonyl and
amide of Val230, while O2 and O3 of the ribose interact
with the carboxylate side chain of Glu270. The guanidino
side chain of Arg235 also appears to make weak hydro-
gen bonds with O8 of the uracil and O2 of the ribose. The
NH2 moiety of Arg235 of AviGT4 makes a 2.9 A˚ H bond to
O2 of ribose. Chemically, this mirrors a similar interaction
in WaaG with Arg173, but the latter is derived from a com-
pletely different secondary structural element. The a-
phosphate of UDP makes weak interactions with the
backbone amides of Thr266 and Val267, while the b-
phosphate hydrogen bonds to the side chain of Tyr39. Fi-
nally, the two faces of the uracil ring make hydrophobic
interactions with the side chain of Tyr39 and Met178.
Although the true nature of the donor sugar is un-
known, AviGT4 is demonstrably the first retaining GT-B
fold structure reported whose donor sugar is not glu-
cose. Based upon the overlap of the WaaG UDP-2FGlc
complex with AviGT4, it is clear that, at the 6 position,
where the AviGT4 donor is a 6-deoxy D-sugar, the envi-
ronment is entirely consistent with a deoxy species in
which Val45 and Ile155 flank the C6 position (Figure 4).
Conversely, the histidine residue implicated in binding
O6 in all GT-B enzymes, apart from WaaG, is also present
in AviGT4. Although it is likely that AviGT4 harnesses a
6-deoxy species, the presence of the highly conserved
histidine leaves this open to speculation. It is possible
that AviGT4 may only accommodate C6-deoxy sugars,
and the retention of the conserved histidine may simply
be a remnant of its role in stabilizing the oxocarbenium
transition state formed during the course of the reaction.AviGT4 contains a number of residues whose interac-
tions are likely invariant with respect to WaaG. These in-
clude Glu262, which interacts with O3 and the main-
chain amides of Pro263, Gly264, and Ala265, which cor-
respond to Ala282, Ala283, and Gly284 of WaaG and
which are thus implicated in the recognition of O2 and
O3. Together, these observations imply that the donor
sugar for AviGT4 may be in gluco configuration, consis-
tent with the equatorial orientations of these groups in
the eurekanate moiety. The mechanism by which AviGT4
interacts with the acetyl group appended to C4 and of the
galacto-configured O4 is unclear. Indeed, as the nature
of the sugar is unknown, it is possible that the donor
sugars lack some of the eurekanate-specific signatures
seen in the final product. It is interesting to note, how-
ever, that in a complex of AviGT4 with UDP-Glc, the glu-
cosyl moiety of UDP-Glc is located in the acceptor (‘‘+1’’
nomenclature adapted from [26]) subsite rather than the
donor sugar binding site of the Streptomyces enzyme,
indicating that the glycon transferred by AviGT4 is likely
quite distinct from glucose.
The Acceptor Sites of WaaG and AviGT4
Show Remarkable Diversity
Inspection of WaaG and AviGT4 shows small changes in
the donor site, consistent with the nature of the donor
sugar, but much more substantial changes in the accep-
tor site, reflecting the very different nature of the accep-
tor species. This is reflected in the electrostatic surfaces
(Figure 5), which show a very positively charged surface
for WaaG, reflecting its interaction with the negatively
charged LPS acceptor, yet a very negatively charged
surface for AviGT4; the reason for which is not immedi-
ately obvious. The acceptor binding cavity of WaaG is
a deep and open basin in which the glucosyl moiety of
the donor is found covering the deepest point of its floor.
This pocket encloses an area of about 940 A˚2, and its
shape and volume suggest that it can accommodate
the first two heptose moieties of the acceptor LPS, in-
cluding, if necessary, the heptosyl ramification on the
first of these residues. The walls of the cavity are lined
by four tyrosine residues and with various lysine and ar-
ginine residues pointing directly to the cavity, in line with
the generic signature of carbohydrate binding sites. The
acceptor binding cavity of AviGT4 is also a depression
with a wide aperture, but it is shallower than the WaaG
binding surface. This cavity encloses an accessible sur-
face area of approximately 550 A˚2. The elongated shape
of its opening is reminiscent of the nonbranched nature
of its acceptor, and its dimensions suggest that perhaps
only the first two residues of the avilamycin acceptor are
recognized. These distinct acceptor binding architec-
tures, in stark contrast with, for example, the narrow
cavity that accommodates a single sugar of its closest
structural neighbor, OtsA from family GT-20, expand
the current view of the amazing plasticity that the GT-
B fold can support. These structural variations are found
mainly expressed as alterations in the lengths and orien-
tation of the connecting a helices of the Rossmann fold
in the N-terminal domain.
Catalytic Mechanism of WaaG and AviGT4
The catalytic mechanism of retaining GTs remains elu-
sive (reviewed in [4, 23, 27]). In the absence of a more
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Surface representation of (A) WaaG and (B) AviGT4 colored by electrostatic potential (red, 23kT; blue +3kT, where k is the Boltzmann constant
and T is temperature), calculated by the Adaptive Poisson-Boltzmann Solver (APBS) program [44] and visualized with Pymol (DeLano Scientific
LLC, http://pymol.sourceforge.net/); ligands are shown in licorice representation.convincing mechanism, most authors have converged
on a mechanism involving ‘‘front-face’’ chemistry; an
SNi-like reaction in which leaving-group departure and
nucleophilic attack occur in a concerted, but necessarily
stepwise, manner on the same face of the glycoside
(see [13, 28], for example). In practice, this mechanism
is favored primarily because of the lack of evidence
(such as the presence of a conserved potential nucleo-
phile that could attack C1 from the ‘‘b-face’’ of the sugar
in a classic double displacement retaining reaction) sup-
porting any alternative mechanism. The structure of
WaaG is consistent with these proposals, for it displays
the signature features of the GT-B fold retaining en-
zymes, notably a carbonyl moiety ‘‘above’’ C1, believed
to stabilize the developing positive charge on the transi-
tion state [22] and the environment around the b-phos-
phate, which favors its interaction with the incoming
nucleophile.
The mechanism by which AviGT4 catalyzes glycosyl
transfer is less clear, as the eurekanate displays both
a and b glycosidic bonds with L-lyxose, and, thus, could
mediate the first glycosyl transfer via an inverting or re-
taining mechanism. It is generally believed that, as with
glycoside hydrolase families, the mechanism of glycosyl
transfer is conserved in the members of the same GT
family, suggesting that AviGT4 is a retaining GT. This
view is strongly supported by the topology and nature
of its active site, which displays the signature features
of a retaining enzyme, such as the conserved carbonyl
moiety above C1 and the carboxylate interaction around
O3. The mechanism by which the second glycosidiclinkage is made is unknown; however, one can speculate
that hydride abstraction from C1 would be required to
activate this center for attack, but the enzyme(s) re-
sponsible have not been identified. Similarly, the double
substituent at C4 might favor nucleophilic attack to C4,
on a species already containing the ketone moiety, but,
again, the synthetic pathway remains speculative.
Comparison with Other GT Families
The CAZY classification of protein sequences into fam-
ilies is organized on the basis of sequence similarity to
one or more experimentally characterized founding
family members. With the improvement of sequence de-
tection methods, and with solved 3D structures, more
distant relationships can be detected among different
families. These interfamily relationships allow for the
implementation of a hierarchical organization of families
into clans and folds [2]. For GTs, only two different folds
(and minor variations thereof), the GT-A and GT-B fold,
are currently described for the 87 sequence families,
but there is currently no correlation of fold with mecha-
nism; nor is there a robust way of ascertaining the mech-
anism of catalysis from sequence alone, especially since
the sequence similarities between families are extremely
low. Three-dimensional structure comparison, through
experimentally determined 3D structure, is arguably
the most powerful method of inferring protein struc-
ture-function relatedness, especially when sequence
identities are very low and sequence-based comparison
methods are at the border of significance. Through the
structural data for two members of the GT4 family,
Structure of Two Family GT4 Glycosyltransferases
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(A) Phylogenetic tree displaying the distances among the 18 C-terminal domains of GTs and glycogen phosphorylases obtained from a multiple
sequence alignment derived, in turn, from the structural superposition of the 3D coordinates. The phylogram was drawn with TreeView [41],
and the structural superposition and alignment was carried out with SSM [39]. An asterisk indicates the unusual inverting sialyltransferase,
which is found in the ‘‘retaining’’ side of the division (discussed in text).
(B) Cartoon representation of the 3D alignment. Inverting GTs are colored red, while retaining GTs are colored blue. Two glucosyl recognition
sites are highlighted in yellow: one derived from the retaining GT4 WaaG (this work), and the other in the inverting GT1 VvGT1 [14].reported here, it is possible to investigate the evolution-
ary relationship of this family with the rest of the struc-
turally characterized members of the GT-B fold. Phylo-
genetic trees, based upon 3D structure-derived
overlaps of the divergent sequences, treating the flexi-
ble N- and C-terminal domains independently, present
intriguing results.
When sequence alignments, derived from the struc-
tural superposition of the separated 18 C-terminal do-
mains, are visualized in phylogenetic trees, a clear sepa-
ration of the inverting and retaining enzymes is apparent
(Figure 6A). The sole ‘‘outlier’’ is the inverting GT80 cyti-
dine 50-monophosphate sialyltransferase (marked with
an asterisk in the phylogenetic tree), which appears on
the ‘‘retaining’’ side of the tree. The GT80 enzyme is
also unusual in many other ways in that it uses a nucleo-
side monophosphate donor, has also been reported to
catalyze transglycosylation with retention (in addition
to glycosyl transfer with inversion), and lacks the typical
signature of the GT-B fold of C-terminal a helix crossing
over to the N-terminal domain [29]. The tree, the con-struction of which was only possible with the information
provided by the 3D structures, not only allows the dis-
crimination of catalytic activity, but also places both
GT4 sequences clearly on the ‘‘cusp’’ of retaining and
inverting enzymes, again providing support for their
role as ancestral GTs first suggested by analysis of
genome sequences (discussed previously).
The structural overlap of these C-terminal domains
(Figure 6B) is equally provocative. While there is a
remarkable structural conservation of the nucleotide
binding region, there is a clear division between those el-
ements used to bind the donor sugar moiety in inverting
and retaining enzymes. In retaining GTs, this recognition
site is generally located in the loop that connects the Cb4
strand with the Ca4 helix, as observed in the complex of
retaining GT4s, AviGT4 and WaaG (reported here), and
GT20 OtsA [12] with their intact nucleotide-sugar donors.
In retaining enzymes, and in AviGT4 especially, this loop
is longer and more flexible than its counterparts in the in-
verting architectures. Inverting enzymes display a short
and structural conserved loop that leaves the region
Chemistry & Biology
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implemented in the loop connecting the Cb5 strand
with the Ca5 helix instead, as observed in the complexes
of the two plant GT-1 GTs [14, 30] and GT-28 MurG [17]
with their intact nucleotide-sugar donors. Exceptions
to this generality are the retaining GT-72 [16] and invert-
ing GT-63 DNA glucosyltransferase [31], where the glu-
cosyl moiety is principally recognized by residues in
the N-terminal domain in both cases. Although the enzy-
matic mechanisms for retaining GTs are ill-defined, the
different structural preferences of the inverting and re-
taining GTs in relation to the relative spatial disposition
of the sugar moiety of the sugar-nucleotide to the accep-
tor, in otherwise very similar molecular architectures,
again presents an easy evolutionary switch between
the SN2-like inversion mechanism and the ‘‘front face
only’’ mechanism for retention—a feature that we had
discussed previously for GT-A fold enzymes [28].
Significance
This report describes the crystal structures of two gly-
cosyltransferase (GT) family 4 enzymes that, although
displaying low sequence identity, exhibit a very similar
protein structure, termed the GT-B fold, and active site
topology. Differences in the donor sugar sites reflect
the nature of the sugar donors of the two enzymes.
UDP-glucose is the known donor for the lipopolysac-
charide synthesizing a-1,3 glucosyltransferase WaaG,
whereas AviGT4 likely uses a deoxy sugar donor dur-
ing the synthesis of the orthosomycin antibiotic avila-
mycin A. The GT-B fold displays two domains, which,
again with GT4, reflects a diverse acceptor binding
N-terminal domain, but a more conserved nucleotide-
sugar binding C-terminal domain. Such a GT-B fold
has now been observed in around 18 different GT
structures, both those performing catalysis with inver-
sion and those with retention of anomeric configura-
tion. The structures of GT4members of this fold family
are especially important, sinceGT4 is the largest of the
GT-B fold families and the largest family of retaining
GTs of any fold. The structures add to an emerging
picture that GT4 may be an ‘‘ancestral’’ retaining fam-
ily. It is the only family of retaining GTs seen in small,
primitivegenomes, itwasonly throughGT4sequences
that Wrabl and Grisin [18] were able to detect the links
between many of the diverse GTs in their superfamily
classification (theGT4 familydisplays thehighest level
of connectivity with other families), and, here, we addi-
tionally show that phylogenetic trees based upon the
structure-derived sequence alignments place both
GT4 sequences at the cusp of a clear inverting versus
retaining divide. Furthermore, the structural overlap
of all 18 GT-B enzymes, described here, also shows
a clear structural basis for the inverting versus retain-
ing enzymes based upon the topology of the loops in-
teracting with the donor sugar itself.
Experimental Procedures
AviGT4 Protein Production
The AviGT4 gene was amplified by the polymerase chain reaction
(PCR) [32] from Streptomyces viridochromogenes (DMS 40,721)
with genomic DNA and the primers 50-CACCACCACCAC ATGAGGCCGTTGAAGGTGGCGCTGGTC-30 and 50-GAGGAGAAGGCGCG
TTATCACTTCCAGGTCGCTCC-30 to incorporate sequences (in
bold) designed to generate compatible overhangs with a pET28a-
based ligation-independent cloning (LIC) vector [32], incorporating
an N-terminal hexahistidine tag. Competent E. coli BL21(DE3)-RP
strain (Stratagene) was transformed with the recombinant plasmid
pETYSBLIC-aviGT4 (pET28a containing avigt4) and grown at 37C
in Luria-Bertani broth supplemented with 35 mg ml21 kanamycin
and 50 mg ml21 chloramphenicol to an OD600 of 0.4. Cultures were
transferred to a 16C environment and grown until an OD600 of 0.7
was achieved. Expression of avigt4 was induced by the addition of
1 mM isopropyl-b-D-thiogalactopyranoside and incubation at 16C
for 20 hr.
Harvested cells were resuspended in 25 mM HEPES-NaOH
(pH 7.3), 400 mM NaCl, 10% glycerol, 5 mM DTT, and 0.5% Triton
X-100 and incubated for 30 min on ice after the addition of 0.1 mg/ml
lysozyme. Cell disruption was carried out by ultrasonication, and
the lysate was centrifuged at 15,000 3 g for 40 min. Clear, cell-free
extract was loaded onto a 5 ml Ni2+-charged His-Trap column
(Amersham). Unbound proteins and detergent were removed by
washing extensively with 20 mM HEPES-NaOH (pH 7.3), 400 mM
NaCl, and 10% glycerol. AviGT4 was eluted with a 0–500 mM imidaz-
ole gradient. Fractions containing AviGT4 were pooled, concen-
trated, and buffer-exchanged to 20 mM HEPES-NaOH (pH 7.3),
150 mM NaCl, 10% glycerol with a 10 kDa cut-off ultrafiltration
device (Vivaspin). AviGT4 purity and homogeneity was assessed
by SDS-PAGE and gel filtration chromatography. SeMet-labeled
AviGT4 was produced in E. coli B834 (DE3) cells containing
pETYSBLIC-aviGT4 after first culturing in minimal medium contain-
ing seleno-L-methionine. SeMet-labeled AviGT4 expression and
purification was carried out following the same protocols used
with the native protein. SeMet incorporation was checked by mass
spectrometry (data not shown).
Crystallization and Structure Determination of AviGT4
Crystals of AviGT4 and Se-Met AviGT4 were grown by vapor phase
diffusion by the hanging-drop method. Crystallization of AviGT4 (13
mg/ml) and SeMet AviGT4 (10 mg/ml) was conducted in 18% PEG
3350, 0.2 M Li2SO4, and 0.1 M MES (pH 6.5). Crystals of the complex
of AviGT4 with UDP-glucose (Sigma) were prepared by addition of
10 mM UDP-glucose to the protein solution prior to crystallization.
For cryoprotection, 20% (v/v) glycerol was added to the crystalliza-
tion solution, and crystals were transferred directly into liquid nitro-
gen prior to data collection. A three-wavelength MAD data set was
collected at the European Synchrotron Radiation Facility (ESRF)
on beamline ID 14.3 from a single SeMet AviGT4 crystal. Diffraction
data for the AviGT4 UDP-glucose complex were collected at the
Synchrotron Radiation Source (SRS, Daresbury, UK) on beamline
PX14.1. Both data sets were processed by MOSFLM and scaled
and reduced by SCALA, both from the CCP4 suite [33]. The three
merged Se-MAD datasets were input to SOLVE (version 2.08) [34],
and a total of six Se sites were found corresponding to two AviGT4
molecules in the asymmetric unit. RESOLVE [34] was used to further
improve the phases incorporating two-fold noncrystallographic
symmetry averaging, with the operators automatically derived
from the Se positions. The program ARP-wARP [33] was used to
trace and refine the model. PHASER [35] was used to place the
four AviGT4 molecules in the P1 cell of the AviGT4 UDP-glucose
complex. Both models, AviGT4 with and without ligand, were
manually corrected by COOT [36]. Final refinement cycles were
performed by REFMAC [37], and TLS [38] corrections were incorpo-
rated in the AviGT4 UDP-glucose complex model refinement. Water
molecules were added with the solvent-building options of ARP-
wARP [33] and were manually inspected at the graphic display.
E. coli WaaG Protein Production
ThewaaG gene was amplified by the PCR from E. coli (strain W3110)
with genomic DNA and the primers 50-ATAGGATCCATCGTGGCGT
TTTGTT TATATAAATATTTTCCATTTGGTGG GCTTCAACG -30 and
50-TAGAATTCAACCATCTAAACCACCTGTAATGATATCCGCGGCT
TTTTCTGG-30 (enzyme restriction sites are in bold). The amplified
DNA was digested with BamHI and EcoRI and ligated into suitably
restricted pHISNOTHR (a gift from Prof. A.R. Fersht at the Medical
Structure of Two Family GT4 Glycosyltransferases
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downstream of the sequence encoding a hexahistidine tag.
The waaG gene was expressed in E. coli cell strain C41(DE3)
(Avidis) by induction with isopropyl-b-D-thiogalactopyranoside
(100 mM) at 16C for 16 hr in LB medium supplemented with ampicil-
lin at 50 mg ml21. SeMet-labeledwaaG expression in E. coli cell strain
B834 (Novagen), cultured in SeMet growth medium (Molecular Di-
mensions) supplemented with ampicillin at 50 mg ml21, was induced
as described above. Bacterial cells were harvested and resus-
pended in 20 mM Tris-HCl buffer (pH 8.0), containing 300 mM
NaCl, 0.5% Triton X-100, and 1 mM TCEP (buffer A), disrupted by ul-
trasonication, and the cell-free extract was applied to a 5 ml TALON
affinity resin (Clontech). After washing with buffer B (buffer A lacking
Triton X-100), WaaG was eluted from the resin with Buffer B,
containing an imidazole gradient (5–100 mM over 100 ml), and the
imidazole removed by size exclusion chromatography. WaaG was
further purified with a G75 26/60 column (Amersham Pharmacia),
and the eluted enzyme was concentrated to 10 mg/ml (determined
with a molar extinction coefficient value of 41,390 at 280 nm
wavelength).
Crystallization and Structure Determination of E. coli WaaG
Crystals of WaaG and of its SeMet derivative were grown in 0.1 M
MES (pH 6.75), 0.2 M NaBr, and 15% PEG 3350 at a protein concen-
tration of 10 mg/ml. Microseeding was necessary to achieve re-
producibility of the crystals. Crystals of the complex of WaaG with
UDP-2F-glucose were prepared by addition of 10 mM UDP-2F-glu-
cose to the protein solution prior to crystallization. For cryoprotec-
tion, 22% (v/v) glycerol was added to the crystallization solution,
and crystals were transferred directly into liquid nitrogen prior to
data collection. A SAD data set was collected at the ESRF on beam-
line ID 14.4 from a single SeMet WaaG crystal. Diffraction data for the
WaaG UDP-2F-glucose complex were collected in house. All data
were processed by MOSFLM from the CCP4 suite [33]. SOLVE/
RESOLVE (version 2.09) [34] were used to find the six Se sites and
phase the diffraction data, resulting in a readily interpretable map
in which ARP-wARP [33] could trace and refine the model. Subse-
quently, UDP and UPD-2F-Glc were added manually and the model
corrected by COOT [36]. Final refinement cycles were performed
with REFMAC [37].
Structure-Based Sequence Alignment
The structural superposition of the 18 C-terminal domains was
carried out with secondary-structure matching (SSM; [39]). This
program produces a sequence alignment derived from the structural
superposition that was read into CLUSTAL W program [40] in order
to calculate intersequence distances and produce a neighbor-join-
ing tree. This tree was visualized as a phylogram with TreeView [41].
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